TipRanks
MoonLake Immunotherapeutics (MLTX)
NASDAQ:MLTX
US Market
MLTX
MoonLake Immunotherapeutics
RESEARCH TOOLSreports
Want to see MLTX full AI Analyst Report?

MoonLake Immunotherapeutics (MLTX) Stock News & Sentiment

677 Followers
MoonLake: Buy Rating Reaffirmed as BLA Progress, Strong HS Data Support Unchanged $34 Price Target
Premium
Ratings
MoonLake: Buy Rating Reaffirmed as BLA Progress, Strong HS Data Support Unchanged $34 Price Target
5d ago
MLTX
MoonLake files FDA application for sonelokimab therapy
Premium
Company Announcements
MoonLake files FDA application for sonelokimab therapy
10d ago
8K
MLTX
MoonLake announces positive Phase 3 psoriatic arthritis results
Premium
Company Announcements
MoonLake announces positive Phase 3 psoriatic arthritis results
2M ago
8K
MLTX
MLTX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
MLTX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
MLTX
Analyst Maintains Buy on MoonLake, Reiterates $45 Price Target on Strong Financing and Sonelokimab Commercial Potential
Premium
Ratings
Analyst Maintains Buy on MoonLake, Reiterates $45 Price Target on Strong Financing and Sonelokimab Commercial Potential
3M ago
MLTX
MoonLake Immunotherapeutics Announces $200 Million Public Offering
Premium
Company Announcements
MoonLake Immunotherapeutics Announces $200 Million Public Offering
4M ago
8K
MLTX
Buy Rating Reaffirmed on Sonelokimab’s Strong HS Data and Regulatory De-Risking; $30 Price Target Maintained
Premium
Ratings
Buy Rating Reaffirmed on Sonelokimab’s Strong HS Data and Regulatory De-Risking; $30 Price Target Maintained
4M ago
MLTX
More MLTX News >

MLTX News on the Web

MoonLake Immunotherapeutics (MLTX) Files BLA for Sonelokimab to Treat Hidradenitis Suppurativa
GuruFocus News
Bullish
Analysts’ Opinions Are Mixed on These Healthcare Stocks: MoonLake Immunotherapeutics (MLTX) and Liquidia Technologies (LQDA)
TipRanks News
Bullish
Analysts Conflicted on These Healthcare Names: Jade Biosciences (JBIO), MoonLake Immunotherapeutics (MLTX) and Quanterix (QTRX)
TipRanks News
Bullish
MoonLake shares drop 11% pre-market after Q2 earnings, Phase 3 trial results
TipRanks News
Neutral
Insider Sell: Santos da Silva Jorge Sells 102,225 Shares of MoonLake Immunotherapeutics (MLTX)
GuruFocus News
Bearish
BIOTECHNOLOGY VALUE FUND L P's Strategic Acquisition in MoonLake Immunotherapeutics
GuruFocus News
Bullish
MoonLake Immunotherapeutics' CFO Sells 39K Shares
The Motley Fool
Bearish
Insider Sell: Santos da Silva Jorge Sells 47,775 Shares of MoonLake Immunotherapeutics (MLTX)
GuruFocus News
Neutral

News Score - Last 7 Days

Positive
MLTX
Sector Average
Media Buzz
This Week2 articles
Weekly Average1.5 articles
News Sentiment
This Week100%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is MLTX’s Media Buzz Sentiment?
2 articles about MLTX were published this week. In an average week, 1.5 articles are published.
    What is MLTX’s weekly average amount of articles?
    In an average week, 1.5 articles about MLTX are published.
      What is MLTX’s News Sentiment?
      100% of articles about MLTX were positive this week, compared to its sector average of 91%.
        Healthcare Stocks that are Trending in the News
        CMXHFCSL
        RZLTRezolute
        AMGNAmgen
        PMCUFPro Medicus Limited
        ABTAbbott Laboratories
        Showing the stocks with the most bullish news sentiment over the past week